Renata

Passionate about delivering value to patients

[Renata @EteraRela]

Excited about attending the 17th conference of Epilepsy Therapies & Diagnostics Development and presenting about the novel approach in treatment of seizures associated with TSC. https://t.co/of0mU7cimm

[Renata @EteraRela]

Today, on the TSC Global Awareness Day, and every day working with TSC community, we are reminded about the importance of providing better treatment alternatives to people living with TSC. At Noema Pharma we hope to bring more clarity to understanding the…https://t.co/vA7AtWjkEm

[Renata @EteraRela]

Three years ago on the TSC Global Awareness Day I started to work for Noema Pharma and became part of the company's work developing Basimglurant for treating seizures in people with TSC. This continues to be an exciting journey and we are grateful for bec…https://t.co/H32aczbyri

[Renata @EteraRela]

Looking for a role in an environment driven by innovation where you can put the needs of patients in the center? Here is a great opportunity! https://t.co/muAXOZYviz

[Renata @EteraRela]

Exciting to have the support for Noema Pharma and all the work we do for patients with conditions of the central nervous system to help people live their lives to the fullest.
#patientcentric #drugdevelopment https://t.co/fKzy8yTgaM

[Renata @EteraRela]

February is Heart Health month 💖 - watch out for interesting facts from CorDiFio Health https://t.co/9dvXRlRavD

[Renata @EteraRela]

So much learning, so many connections at #aes2022

Privileged to be part of this community #community #pharma as Noema Pharma is working to bring treatment alternatives to people with TSC associated seizures. https://t.co/Q0sK5o5hUk

[Renata @EteraRela]

1 in 2,000 children is diagnosed with infantile spasms. While rare, infantile spasms are a medical emergency and should never be taken lightly. Learn more at to make sure wach child gets the attention it needs.
December 1-7 is Inf…https://t.co/OkDPf6SEv9 https://t.co/7ZC4KGf7jP

[Renata @EteraRela]

Responding to this need, we at Noema Pharma are working to develop a new treatment option for patients with TSC associated seizures. As mGlu5 receptor inhibitor, Basimglurant decreases the neuronal excitibility through a novel mechanism of action. As our…https://t.co/8EuYVCyygt

[Renata @EteraRela]

As we are recapping the work we have done this year, TSC World conference 2022 stands out as a remarkable learning for Noema Pharma team.
Developing basimglurant for treating seizures in children adolescents and young adults with TSC, this fabulous event…https://t.co/0wamFTXaSF

[Renata @EteraRela]

Do you/your loved ones have experience with Tourette Syndrome? Noema Pharma is running a clinical program in TS and because patient centricity is one of our foundational principles, we want to understand what people living with TS need.
Thank you, Dr Seo…https://t.co/qC6ISOP5ir

[Renata @EteraRela]

Read pages 14-15 to learn about the trial with Basimglurant, a new mechanism of action aiming to control seizures in TSC. The trial is run by Noema Pharma in partnership with TSC Alliance. Focusing on the needs of individuals with TSC, we hope to bring be…https://t.co/6IG88dDbvw

[Renata @EteraRela]

This paradigm shift also reflects the reality of healthcare professional - patient relationship in broader sense. Gone are the times when patients just listened what the doctor has to say and much more patient is becoming a partner in making decisions on…https://t.co/4k32CDDNKe

[Renata @EteraRela]

Noema Pharma team at the TSC World Conference in Dallas - what an experience! We have interacted with families, clinical sites and patient organisations and learned so much about the needs of people living with TSC.
As part of TSC community, more than e…https://t.co/eqxnB16dnD

[Renata @EteraRela]

Noema Pharma team is excited to attend the TSC World conference in Dallas next week - not only we will be able to deeper connect with the TSC community, further build awareness of the Galene trial with basimglurant in seizures asso…https://t.co/Sggz6Y5jGt https://t.co/DpzEHcEcrS

[Renata @EteraRela]

Families with Tuberous sclerosis complex in Ukraine are fighting on two fronts: with the disease and for freedom of their country. Very touching tribute to today‘s Global TSC awareness day! https://t.co/p2QLcPb1FM

[Renata @EteraRela]

When I joined Noema Pharma in May 2020, it definitely felt like a good omen to start working on a Tuberous Sclerosis Complex program the same day the community is celebrating the Global TSC awareness day on May 15.
Two years (and…https://t.co/nHQHaqBhBu https://t.co/hTgu6ToW1B

[Renata @EteraRela]

As exciting as these news are and the value it brings to patients with a great medical need, it might deepen health inequities if inclusive research will not address the needs of minority patients as well #inclusive https://t.co/crsajQQ7X3

[Renata @EteraRela]

might not have as much eyesight as most, but has more insight than many #peoplewithdisabilities https://t.co/YG9b6H2vbt

[Renata @EteraRela]

Presenting Agile and employers perspective on inclusion at the FHNW School of Life Sciences Postgraduate program Systemic Perspectives of Integration - great to see the attenddees’ engagement and desire to reimagine their work at social work organizations…https://t.co/mWEKDLoqMG